Literature DB >> 27548819

Systemic Adenosine Triphosphate Impairs Neutrophil Chemotaxis and Host Defense in Sepsis.

Xiaoou Li1, Yutaka Kondo, Yi Bao, Laura Staudenmaier, Albert Lee, Jingping Zhang, Carola Ledderose, Wolfgang G Junger.   

Abstract

OBJECTIVE: Sepsis remains an unresolved clinical problem. Therapeutic strategies focusing on inhibition of neutrophils (polymorphonuclear neutrophils) have failed, which indicates that a more detailed understanding of the underlying pathophysiology of sepsis is required. Polymorphonuclear neutrophil activation and chemotaxis require cellular adenosine triphosphate release via pannexin-1 channels that fuel autocrine feedback via purinergic receptors. In the current study, we examined the roles of endogenous and systemic adenosine triphosphate on polymorphonuclear neutrophil activation and host defense in sepsis.
DESIGN: Prospective randomized animal investigation and in vitro studies.
SETTING: Preclinical academic research laboratory.
SUBJECTS: Wild-type C57BL/6 mice, pannexin-1 knockout mice, and healthy human subjects used to obtain polymorphonuclear neutrophils for in vitro studies.
INTERVENTIONS: Wild-type and pannexin-1 knockout mice were treated with suramin or apyrase to block the endogenous or systemic effects of adenosine triphosphate. Mice were subjected to cecal ligation and puncture and polymorphonuclear neutrophil activation (CD11b integrin expression), organ (liver) injury (plasma aspartate aminotransferase), bacterial spread, and survival were monitored. Human polymorphonuclear neutrophils were used to study the effect of systemic adenosine triphosphate and apyrase on chemotaxis.
MEASUREMENTS AND MAIN RESULTS: Inhibiting endogenous adenosine triphosphate reduced polymorphonuclear neutrophil activation and organ injury, but increased the spread of bacteria and mortality in sepsis. By contrast, removal of systemic adenosine triphosphate improved bacterial clearance and survival in sepsis by improving polymorphonuclear neutrophil chemotaxis.
CONCLUSIONS: Systemic adenosine triphosphate impairs polymorphonuclear neutrophil functions by disrupting the endogenous purinergic signaling mechanisms that regulate cell activation and chemotaxis. Removal of systemic adenosine triphosphate improves polymorphonuclear neutrophil function and host defenses, making this a promising new treatment strategy for sepsis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27548819      PMCID: PMC5546305          DOI: 10.1097/CCM.0000000000002052

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

1.  The search for effective therapy for sepsis: back to the drawing board?

Authors:  Derek C Angus
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

3.  ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

Authors:  Yu Chen; Ross Corriden; Yoshiaki Inoue; Linda Yip; Naoyuki Hashiguchi; Annelies Zinkernagel; Victor Nizet; Paul A Insel; Wolfgang G Junger
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

4.  Mitochondria regulate neutrophil activation by generating ATP for autocrine purinergic signaling.

Authors:  Yi Bao; Carola Ledderose; Thomas Seier; Amelie F Graf; Bianca Brix; Eritza Chong; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

Review 5.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

Review 6.  Immune cell regulation by autocrine purinergic signalling.

Authors:  Wolfgang G Junger
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

Review 7.  Pannexin channels and their links to human disease.

Authors:  Silvia Penuela; Luke Harland; Jamie Simek; Dale W Laird
Journal:  Biochem J       Date:  2014-08-01       Impact factor: 3.857

Review 8.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

9.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance.

Authors:  Michael R Elliott; Faraaz B Chekeni; Paul C Trampont; Eduardo R Lazarowski; Alexandra Kadl; Scott F Walk; Daeho Park; Robin I Woodson; Marina Ostankovich; Poonam Sharma; Jeffrey J Lysiak; T Kendall Harden; Norbert Leitinger; Kodi S Ravichandran
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

Review 10.  The role of pannexin1 in the induction and resolution of inflammation.

Authors:  Samantha E Adamson; Norbert Leitinger
Journal:  FEBS Lett       Date:  2014-03-15       Impact factor: 4.124

View more
  19 in total

1.  Frontline Science: Escherichia coli use LPS as decoy to impair neutrophil chemotaxis and defeat antimicrobial host defense.

Authors:  Yutaka Kondo; Carola Ledderose; Christian J Slubowski; Mahtab Fakhari; Yuka Sumi; Koichiro Sueyoshi; Ann-Katrin Bezler; Dilan Aytan; Mona Arbab; Wolfgang G Junger
Journal:  J Leukoc Biol       Date:  2019-08-08       Impact factor: 4.962

2.  Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors.

Authors:  Koichiro Sueyoshi; Carola Ledderose; Yong Shen; Albert H Lee; Nathan I Shapiro; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2019-02-20       Impact factor: 5.157

3.  Probenecid Relieves Cerebral Dysfunction of Sepsis by Inhibiting Pannexin 1-Dependent ATP Release.

Authors:  Zhanqin Zhang; Yi Lei; Chaoying Yan; Xiaopeng Mei; Tao Jiang; Zhi Ma; Qiang Wang
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  Optimized HPLC method to elucidate the complex purinergic signaling dynamics that regulate ATP, ADP, AMP, and adenosine levels in human blood.

Authors:  Carola Ledderose; Eleftheria-Angeliki Valsami; Wolfgang G Junger
Journal:  Purinergic Signal       Date:  2022-02-07       Impact factor: 3.950

5.  The Pannexin-1 Channel Inhibitor Probenecid Attenuates Skeletal Muscle Cellular Energy Crisis and Histopathological Injury in a Rabbit Endotoxemia Model.

Authors:  Huaiwu He; Dawei Liu; Yun Long; Xiaoting Wang; Bo Yao
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

6.  Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte/Macrophage Activation, Inflammasome Signaling, Interleukin-1β Production, and the Host Immune Response to Infection.

Authors:  Albert H Lee; Carola Ledderose; Xiaoou Li; Christian J Slubowski; Koichiro Sueyoshi; Laura Staudenmaier; Yi Bao; Jingping Zhang; Wolfgang G Junger
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

Review 7.  Neutrophils: fast and furious-the nucleotide pathway.

Authors:  Dominique S Rubenich; Priscila O de Souza; Natalia Omizzollo; Gabriela S Lenz; Jean Sevigny; Elizandra Braganhol
Journal:  Purinergic Signal       Date:  2021-04-29       Impact factor: 3.765

Review 8.  Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-06-09       Impact factor: 4.871

Review 9.  Mechanisms of ATP Release by Inflammatory Cells.

Authors:  Michel Dosch; Joël Gerber; Fadi Jebbawi; Guido Beldi
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

Review 10.  Ectonucleotidases in Intestinal and Hepatic Inflammation.

Authors:  Marta Vuerich; Simon C Robson; Maria Serena Longhi
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.